Trial Profile
Rapid ferric carboxymaltose infusion (Ferinject) for Iron Deficiency Anaemia in Aboriginal children: a randomised controlled trial
Status:
Recruiting
Phase of Trial:
Phase III/IV
Latest Information Update: 27 Aug 2019
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms RIIS
- 26 Aug 2019 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 New trial record